Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,598 | 167 | 99.9% |
| Education | $4.79 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,270 | 47 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $298.06 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $290.43 | 10 | $0 (2023) |
| EMD Serono, Inc. | $287.02 | 6 | $0 (2024) |
| Neurelis, Inc. | $226.76 | 5 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $220.77 | 3 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $211.26 | 10 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $202.76 | 4 | $0 (2024) |
| Lundbeck LLC | $185.68 | 4 | $0 (2024) |
| Lilly USA, LLC | $180.48 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $988.66 | 28 | ABBVIE INC. ($477.23) |
| 2023 | $819.92 | 31 | ABBVIE INC. ($367.78) |
| 2022 | $1,142 | 45 | Novartis Pharmaceuticals Corporation ($162.04) |
| 2021 | $1,652 | 64 | AbbVie Inc. ($296.32) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $115.72 | General |
| Category: Rare Disease | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/16/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Neuroscience | ||||||
| 08/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: PAIN | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $97.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Neuroscience | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: PAIN | ||||||
| 07/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: PAIN | ||||||
| 07/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/20/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Neuroscience | ||||||
| 06/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.56 | General |
| 05/16/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neurology | ||||||
| 05/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: PAIN | ||||||
| 05/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $12.64 | General |
| 04/22/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Neurology | ||||||
| 04/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: Neuroscience | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $88.49 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $63.45 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: PAIN | ||||||
| 03/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $34.35 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 199 | 225 | $47,984 | $20,027 |
| 2022 | 5 | 271 | 287 | $61,300 | $25,104 |
| 2021 | 2 | 206 | 223 | $35,785 | $17,596 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 97 | 100 | $24,510 | $10,438 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 93 | $16,890 | $7,203 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,749 | $1,510 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 15 | $1,835 | $875.55 | 47.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 89 | 94 | $22,842 | $10,772 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 138 | $24,455 | $8,880 | 36.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $5,933 | $2,467 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $6,329 | $2,338 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $1,741 | $646.85 | 37.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 169 | $29,575 | $14,313 | 48.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 54 | $6,210 | $3,284 | 52.9% |
About Kayla Taylor, CRNP
Kayla Taylor, CRNP is a Nurse Practitioner healthcare provider based in York, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2021. The National Provider Identifier (NPI) number assigned to this provider is 1013592930.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kayla Taylor, CRNP has received a total of $4,603 in payments from pharmaceutical and medical device companies, with $988.66 received in 2024. These payments were reported across 168 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,598).
As a Medicare-enrolled provider, Taylor has provided services to 676 Medicare beneficiaries, totaling 735 services with total Medicare billing of $62,728. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location York, PA
- Active Since 03/11/2021
- Last Updated 03/29/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1013592930
Products in Payments
- QULIPTA (Drug) $557.93
- UBRELVY (Drug) $478.67
- NURTEC ODT (Drug) $365.29
- KESIMPTA (Drug) $298.06
- BOTOX (Biological) $233.44
- VALTOCO (Drug) $226.76
- INGREZZA (Drug) $200.81
- VYEPTI (Biological) $185.68
- EMGALITY (Drug) $160.72
- AUSTEDO (Drug) $145.54
- GORE CARDIOFORM Septal Occluder (Device) $129.51
- Mavenclad (Drug) $125.00
- ZEPOSIA (Drug) $116.69
- ULTOMIRIS (Biological) $115.72
- ADUHELM (Biological) $78.80
- Fycompa (Drug) $78.77
- ONGENTYS (Drug) $69.89
- AJOVY (Biological) $65.72
- OCREVUS (Biological) $60.93
- MAVENCLAD (Drug) $50.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in York
Mrs. Laurel Pszcolka, Crnp, CRNP
Nurse Practitioner — Payments: $6,125
Mallory Evans, Np, NP
Nurse Practitioner — Payments: $4,108
Kerri Neel, Ms Fnp, MS FNP
Nurse Practitioner — Payments: $3,038
Theresa Mollah, Crnp, CRNP
Nurse Practitioner — Payments: $2,813
Angela Johnson, Crnp, CRNP
Nurse Practitioner — Payments: $2,649
Janice Cartwright, Crnp, CRNP
Nurse Practitioner — Payments: $2,007